Healthy volunteers help unlock Casdatifan's drug interactions
NCT ID NCT06919991
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 28 times
Summary
This study looked at how casdatifan, an experimental drug, interacts with two other medicines in 14 healthy adults. Participants took casdatifan alone and then with itraconazole (a strong CYP3A4 inhibitor) or phenytoin (a strong CYP3A4 inducer). The goal was to measure how these combinations affect drug levels in the blood and to check for side effects. This information helps doctors understand how to dose casdatifan safely when used with other drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.